MedTrace Logo

Investigation of Krill Oil in Women with Premenstrual Syndrome

NCT06584669 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 179

Last updated 2024-09-05

No results posted yet for this study

Summary

In this study the effects of different dosages and preparations of krill oil in comparison to placebo on symptoms of premenstrual syndrome in healthy, female adults will be assessed.

Conditions

  • Premenstrual Syndrome

Interventions

DIETARY_SUPPLEMENT

Krill oil

The krill oil capsules contain Superba™ krill oil extracted from Antarctic krill (Euphausia superba).

OTHER

Placebo

The placebo capsules contain a medium-chain triglyceride (MCT) oil obtained by fractionation of coconut and palm kernel oil, which has no detectable levels of EPA, DHA, astaxanthin, or phospholipids.

Sponsors & Collaborators

  • BioTeSys GmbH

    collaborator OTHER

  • Aker BioMarine Human Ingredients AS

    lead INDUSTRY

Principal Investigators

  • Daniel Menzel, PhD · BioTeSys GmbH

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-02-23
Primary Completion
2013-04-11
Completion
2013-08-23

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06584669 on ClinicalTrials.gov